EMEA (Europe, Middle East and Africa) Human Cytomegalovirus Envelope Glycoprotein B Market Report 2018

March 2018 | 108 pages | ID: E491ACB0E21QEN
QYResearch

Abstracts

In this report, the EMEA Human Cytomegalovirus Envelope Glycoprotein B market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Human Cytomegalovirus Envelope Glycoprotein B for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Cytomegalovirus Envelope Glycoprotein B market competition by top manufacturers/players, with Human Cytomegalovirus Envelope Glycoprotein B sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Astellas Pharma Inc.
• Trellis Bioscience, Inc.
• Vakzine Projekt Management GmbH
• VBI Vaccine Inc
• Vical Incorporated

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• CSJ-148
• CyMVectin
• TRL-345
• PPCM
• Cytomegalovirus Vaccine
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Infectious Disease
• Oncology
• Women's Health
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Human Cytomegalovirus Envelope Glycoprotein B Market Report 2018

1 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B OVERVIEW

1.1 Product Overview and Scope of Human Cytomegalovirus Envelope Glycoprotein B
1.2 Classification of Human Cytomegalovirus Envelope Glycoprotein B
  1.2.1 EMEA Human Cytomegalovirus Envelope Glycoprotein B Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Human Cytomegalovirus Envelope Glycoprotein B Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 CSJ-148
  1.2.4 CyMVectin
  1.2.5 TRL-345
  1.2.6 PPCM
  1.2.7 Cytomegalovirus Vaccine
  1.2.8 Others
1.3 EMEA Human Cytomegalovirus Envelope Glycoprotein B Market by Application/End Users
  1.3.1 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Infectious Disease
  1.3.3 Oncology
  1.3.4 Women's Health
  1.3.5 Others
1.4 EMEA Human Cytomegalovirus Envelope Glycoprotein B Market by Region
  1.4.1 EMEA Human Cytomegalovirus Envelope Glycoprotein B Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Human Cytomegalovirus Envelope Glycoprotein B (2013-2025)
  1.5.1 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2013-2025)

2 EMEA HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Human Cytomegalovirus Envelope Glycoprotein B Market Competition by Players/Manufacturers
  2.1.1 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Players (2013-2018)
2.2 EMEA Human Cytomegalovirus Envelope Glycoprotein B (Volume and Value) by Type/Product Category
  2.2.1 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Type (2013-2018)
2.3 EMEA Human Cytomegalovirus Envelope Glycoprotein B (Volume) by Application
2.4 EMEA Human Cytomegalovirus Envelope Glycoprotein B (Volume and Value) by Region
  2.4.1 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Region (2013-2018)

3 EUROPE HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales and Value (2013-2018)
  3.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2013-2018)
3.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share by Type
3.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share by Application
3.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume by Countries (2013-2018)
  3.4.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Countries (2013-2018)
  3.4.3 Germany Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  3.4.4 France Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  3.4.5 UK Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  3.4.6 Russia Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  3.4.7 Italy Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)

4 MIDDLE EAST HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales and Value (2013-2018)
  4.1.1 Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2013-2018)
4.2 Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share by Type
4.3 Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share by Application
4.4 Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  4.4.4 Israel Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  4.4.5 UAE Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  4.4.6 Iran Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)

5 AFRICA HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Human Cytomegalovirus Envelope Glycoprotein B Sales and Value (2013-2018)
  5.1.1 Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2013-2018)
5.2 Africa Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share by Type
5.3 Africa Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share by Application
5.4 Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Volume by Countries (2013-2018)
  5.4.2 Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Countries (2013-2018)
  5.4.3 South Africa Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2013-2018)

6 EMEA HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Astellas Pharma Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Cytomegalovirus Envelope Glycoprotein B Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Trellis Bioscience, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Human Cytomegalovirus Envelope Glycoprotein B Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Vakzine Projekt Management GmbH
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Human Cytomegalovirus Envelope Glycoprotein B Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 VBI Vaccine Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Human Cytomegalovirus Envelope Glycoprotein B Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Vical Incorporated
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Human Cytomegalovirus Envelope Glycoprotein B Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview

7 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MANUFACTURING COST ANALYSIS

7.1 Human Cytomegalovirus Envelope Glycoprotein B Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Cytomegalovirus Envelope Glycoprotein B Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Cytomegalovirus Envelope Glycoprotein B Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET FORECAST (2018-2025)

11.1 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Human Cytomegalovirus Envelope Glycoprotein B Price and Trend Forecast (2018-2025)
11.2 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Type (2018-2025)
11.7 EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Cytomegalovirus Envelope Glycoprotein B
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type (Product Category) in 2017
Figure CSJ-148 Product Picture
Figure CyMVectin Product Picture
Figure TRL-345 Product Picture
Figure PPCM Product Picture
Figure Cytomegalovirus Vaccine Product Picture
Figure Others Product Picture
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Application in 2017
Figure Infectious Disease Examples
Table Key Downstream Customer in Infectious Disease
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Women's Health Examples
Table Key Downstream Customer in Women's Health
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Market Size (Million USD) by Region (2013-2025)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Status and Forecast by Countries
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Growth Rate (2013-2025)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Players (2013-2018)
Figure 2017 Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Players
Figure 2017 Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Players
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) by Players (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Players (2013-2018)
Table 2017 EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Players
Table 2017 EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Players
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2013-2018)
Figure Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type (2013-2018)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type in 2017
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2013-2018)
Figure Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Application (2013-2018)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2017
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Region (2013-2018)
Figure Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Region (2013-2018)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in 2017
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Region (2013-2018)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Regions in 2017
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2013-2018)
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2013-2018)
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type (2013-2018)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type in 2017
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2013-2018)
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application (2013-2018)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application in 2017
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Countries (2013-2018)
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Countries (2013-2018)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Countries (2013-2018)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Countries in 2017
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) by Countries (2013-2018)
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Countries (2013-2018)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Countries (2013-2018)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Countries in 2017
Figure Germany Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure France Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2013-2018)
Table Middle East Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type (2013-2018)
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type (2013-2018)
Table Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Applications (2013-2018)
Table Middle East Human Cytomegalovirus Envelope Glycoprotein B Market Share by Applications (2013-2018)
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2017
Table Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Countries in 2017
Table Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) by Countries (2013-2018)
Table Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Countries (2013-2018)
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Countries (2013-2018)
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2013-2018)
Table Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2013-2018)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2013-2018)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2017
Table Africa Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2013-2018)
Table Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2013-2018)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2013-2018)
Table Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Countries (2013-2018)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Countries (2013-2018)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Countries in 2017
Table Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) by Countries (2013-2018)
Table Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Countries (2013-2018)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Countries (2013-2018)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Countries in 2017
Figure South Africa Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Table Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Basic Information List
Table Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in EMEA (2013-2018)
Figure Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share in EMEA (2013-2018)
Table Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Basic Information List
Table Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in EMEA (2013-2018)
Figure Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share in EMEA (2013-2018)
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Basic Information List
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in EMEA (2013-2018)
Figure Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share in EMEA (2013-2018)
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Basic Information List
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in EMEA (2013-2018)
Figure VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share in EMEA (2013-2018)
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Basic Information List
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate (2013-2018)
Figure Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in EMEA (2013-2018)
Figure Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Cytomegalovirus Envelope Glycoprotein B
Figure Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
Figure Human Cytomegalovirus Envelope Glycoprotein B Industrial Chain Analysis
Table Raw Materials Sources of Human Cytomegalovirus Envelope Glycoprotein B Major Manufacturers in 2017
Table Major Buyers of Human Cytomegalovirus Envelope Glycoprotein B
Table Distributors/Traders List
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Region (2018-2025)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Region (2018-2025)
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Countries (2018-2025)
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Countries (2018-2025)
Table Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Type (2018-2025)
Table EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources